Featured News - Current News - Archived News - News Categories

Impact of Growth Hormone (GH) Deficiency and GH Replacement upon Thymus Function in Adult Patients

Sat, May 23rd 2009 08:00 pm
http://elitestv.com/pub/2009/05/impact-of-growth-hormone-gh-deficiency-and-gh-replacement-upon-thymus-function-in-adult-patients  [ View Original Article ]

Impact of Growth Hormone (GH) Deficiency and GH Replacement upon Thymus Function in Adult Patients

By PLoS ONE • on May 22, 2009

Background

Despite age-related adipose involution, T cell generation in the thymus (thymopoiesis) is maintained beyond puberty in adults. In rodents, growth hormone (GH), insulin-like growth factor-1 (IGF-1), and GH secretagogues reverse age-related changes in thymus cytoarchitecture and increase thymopoiesis. GH administration also enhances thymic mass and function in HIV-infected patients. Until now, thymic function has not been investigated in adult GH deficiency (AGHD). The objective of this clinical study was to evaluate thymic function in AGHD, as well as the repercussion upon thymopoiesis of GH treatment for restoration of GH/IGF-1 physiological levels.

Methodology/Principal Findings

Twenty-two patients with documented AGHD were enrolled in this study. The following parameters were measured: plasma IGF-1 concentrations, signal-joint T-cell receptor excision circle (sjTREC) frequency, and sj/β TREC ratio. Analyses were performed at three time points: firstly on GH treatment at maintenance dose, secondly one month after GH withdrawal, and thirdly one month after GH resumption. After 1-month interruption of GH treatment, both plasma IGF-1 concentrations and sjTREC frequency were decreased (p<0.001). Decreases in IGF-1 and sjTREC levels were correlated (r = 0.61, p<0.01). There was also a decrease in intrathymic T cell proliferation as indicated by the reduced sj/β TREC ratio (p<0.01). One month after reintroduction of GH treatment, IGF-1 concentration and sjTREC frequency regained a level equivalent to the one before GH withdrawal. The sj/β TREC ratio also increased with GH resumption, but did not return to the level measured before GH withdrawal.

Conclusions

In patients with AGHD under GH treatment, GH withdrawal decreases thymic T cell output, as well as intrathymic T cell proliferation. These parameters of thymus function are completely or partially restored one month after GH resumption. These data indicate that the functional integrity of the somatotrope GH/IGF-1 axis is important for the maintenance of a normal thymus function in human adults.

Trial Registration

ClinicalTrials.gov NTC00601419

For the full article visit: Impact of Growth Hormone (GH) Deficiency and GH Replacement upon Thymus Function in Adult Patients
Syndicated from:PLoS ONE

What is Acromegaly?

Acromegaly is a serious condition caused by a benign tumor in the pituitary gland that releases too much growth hormone into the body.

Further Reading:

Health Guide: Acromegaly

Radiation Treatment

The Gamma Knife

Social Networks:

Myspace
Facebook

Member Login

Username
Password
Remember Me
Forgot Password?
Powered by Fission Content Management | Buffalo Web Design by 360PSG